Dextroamphetamine
Back to searchMolecule Structure
Scientific Name
Dextroamphetamine
Description of the Drug
Dextroamphetamine is a sympathomimetic agent used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01576
http://www.drugbank.ca/drugs/DB01576
Brand Name(s)
Dexedrine, Dextrostat, Xelstrym
Company Owner(s)
Vitarine Pharmaceuticals Inc, Glaxosmithkline, Takeda Pharmaceuticals Usa Inc, Sun Pharmaceutical Industries Inc, Nesher Pharmaceuticals Usa Llc, Halsey Drug Co Inc, Elite Laboratories Inc, Outlook Pharmaceuticals Inc, Rhodes Pharmaceuticals Lp, Shire Development Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Synaptic vesicular amine transporter | SINGLE PROTEIN | INHIBITOR | CHEMBL1893 |
Dopamine transporter | SINGLE PROTEIN | RELEASING AGENT | CHEMBL238 |
Norepinephrine transporter | SINGLE PROTEIN | RELEASING AGENT | CHEMBL222 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL8859 | |||
PharmGKB | PA449269 | PA448408 | ||
Human Metabolome Database | HMDB0015516 | |||
DrugBank | DB01576 | |||
PubChem: Thomson Pharma | 15170721 | |||
PubChem | 5826 | |||
NMRShiftDB | 60021631 | |||
Nikkaji | J4.121A | |||
PDBe | 1WE | |||
BindingDB | 50022723 | |||
EPA CompTox Dashboard | DTXSID8022907 | |||
DrugCentral | 841 | |||
Brenda | 3808 | 40962 | 42060 | |
Guide to Pharmacology | 2147 | |||
rxnorm | DEXTROAMPHETAMINE SULFATE | DEXTROAMPHETAMINE | DEXTROAMPHETAMINE SACCHARATE | DEXEDRINE |
KEGG Ligand | C07884 | |||
ChEBI | 4469 | |||
ZINC | ZINC000006021033 |